How Autonomous Labs Will Transform Scientific Research: Ginkgo Bioworks’ Jason Kelly

Ginkgo Bioworks CEO Jason Kelly: OpenAI reasoning model + robotic lab beats biochemistry state-of-the-art by 40% — and that’s just the start of autonomous science

• Ginkgo + OpenAI: reasoning model running 30,000 experiments over 6 rounds beat Stanford’s cell-free protein synthesis benchmark by 40% — not from smarter reasoning, but 24/7 runtime.
• The bottleneck in science isn’t intelligence — it’s manual labor. Less than 5% of NIH/biopharma R&D budgets go to reagents; the rest is overhead (people, space, equipment).
• 100 parallel AI scientists sharing raw experimental data daily would outperform human labs where results are distilled into papers every 1–2 years and failed experiments are never shared.
• China’s share of novel drug discovery (startup-originated) went from under 5% to 40%+ in one quarter — driven purely by cheaper experimental labor at scale.
• Ginkgo sold 97 autonomous lab robots to DOE’s Project Genesis (Trump White House initiative) to double the speed of US scientific discovery at national labs.
• Humanoids have no place in labs — tracks + robotic arms beat bipedal robots on reliability, precision (micron-level), and density; lab floors don’t change like roads do.
• Scientists now submit protocols in plain language to Claude Code / Codex instead of visual programming tools like LabView — the model generates the robot instructions and the skills file is patched on errors.
• Drug development cost has risen every year for 25 years — Kelly’s thesis: remove humans from benches first, then build the flywheel the way chips replaced vacuum tubes.
• GLP-1 drugs signal biotech’s shift from disease treatment to consumer wellness; Kelly estimates a lifespan-extending biotech product is worth $50T+ — but FDA has no approval pathway for it yet.
• Ginkgo launched cloud lab experiments starting at $39 — thesis: democratizing lab access the way PCs democratized coding, potentially making millions of people citizen scientists.

Guests: Jason Kelly (Ginkgo Bioworks CEO), Sonya Huang (Sequoia Capital), Pat Grady (Sequoia Capital) · 2026-03-24 · Watch on YouTube